Centurion Bioengineering / LANCE

  • Corporation
  • Casual
  • Role play
  • Medical
    Medical
  • Engineering
    Engineering
Join us now!

“Centurion Bioengineering: We Make Humanity Better, One Innovation at a Time.”

History Manifesto Charter

History

A Legacy of Innovation: Centurion Bioengineering

Centurion Bioengineering stands as one of the United Empire of Earth’s most esteemed conglomerates, excelling in the realms of trade, security, and groundbreaking pharmaceutical and genetic research. Established in 2514, just two years prior to the unearthing of Terra Prime, Centurion Bioengineering was the brainchild of Dr. Mattias Clayson, a pioneering geneticist, and Dr. Ariana Embrey, a distinguished biologist. Their vision was to explore novel pharmaceuticals, enriching the lives of the common citizen.

In 2515, the corporation unveiled its first performance-enhancing pharmaceutical, ‘Oxythuid,’ designed initially for military purposes. While the initial trials showed promise, a security breach within the research and development branch inadvertently exposed the drug’s details to the public. This unintentional revelation led to misconceptions, with activists alleging that Centurion sought to create super-soldiers and conducted illicit human trials.

Promptly, the United Nations of Earth (UNE) and private investigative agencies initiated a comprehensive probe. Dr. Clayson and Dr. Embrey cooperated fully, disclosing all information, and the investigation concluded without evidence of human rights violations, putting to rest any legal concerns.

This incident, however, instigated a profound transformation within the private enterprise. By 2516, Centurion Bioengineering had expanded its internal security apparatus to an unprecedented scale. Over a thousand private security personnel were hired, and a dedicated intelligence division was inaugurated to safeguard the corporation and its workforce. During this period, the company chose to maintain its primary headquarters on Terra Prime, erecting an iconic building. This site also facilitated the emergence of its trading division and a robust public relations department.

While publicly presented as a mere expansion of its pharmaceutical interests, the trading division concealed a more covert purpose. With its enduring government contracts, Centurion maintained control over its operations without external oversight, thus ensuring enhanced confidentiality.

The company remained steadfast for several years, with Dr. Clayson and Dr. Embrey retiring from their leadership roles to seek personal tranquility and raise their families. Amid speculations of a potential transition to a publicly traded entity, a new private investor, Tivadar Delgard, assumed control. Mr. Delgard upheld the original mission but was compelled to redirect the company’s resources and advanced pharmaceuticals to support Operation Nemesis, necessitated by the Tevarn contact.

Centurion, once again called upon by the UPE Military, embarked on a mission to explore the vulnerabilities in the Tevarin genome. This endeavor included developing and potentially deploying chemical weapons against the species, a matter still shrouded in secrecy.
While initially hesitant, Delgard accepted the substantial budget allocation, sparking one of the most extensive corporate and governmental conflicts to date. Despite its outward identity as a prominent trading entity with a secure pharmaceutical division, Centurion’s security forces gradually evolved into a formidable entity. By 2555, these forces, with generous funding from pharmaceutical and trading divisions, had become one of the premier private military special forces divisions, specializing in the protection of corporate assets and trade routes.

By 2792, Centurion had retained its enduring image and core functions. However, as UEE intelligence records began to surface regarding past genetic experiments on other races, and in the wake of the Garron II massacre, a crisis loomed. UEE Intelligence initiated a daring raid on Centurion Corporate Headquarters, resulting in a protracted battle. In the end, the operatives barely penetrated the lobby of the company’s iconic building.

With the UEE government faltering, Centurion embarked on a new endeavor. Deploying one of its spec-ops teams amidst the chaos of uprisings and leadership breakdown, the company infiltrated government data centers, erasing any negative information related to the corporation. Simultaneously, its security forces aided the civilian population against oppressive government elements. As a result, Centurion emerged from this transition with newfound public favor and the trust of the restructured UEE government.

In the present day, Centurion Bioengineering, now led by Daiden Kessler, remains as resilient as ever, embracing a forward-looking agenda for an ever-evolving universe. With research and development teams exploring the cosmos and a redesigned trading system, the company has recently disclosed plans to relocate its corporate headquarters to Terra Prime and adopt a new corporate identity adorned in Turquoise Blue and Royal Blue, symbolizing a rebranding from the company’s historical black and gold. The company will also establish state-of-the-art manufacturing centers on Microtech, solidifying its position as a pioneering force in the corporate landscape.

Manifesto

Centurion Bioengineering Manifesto

At Centurion Bioengineering, our purpose is to shape a brighter, healthier future for all of humanity. We are driven by a profound commitment to the betterment of our species, and our journey has been marked by innovation, dedication, and a relentless pursuit of excellence. This manifesto encapsulates our core beliefs and values:

1. Innovation as Our North Star:
We believe in the power of innovation to transform lives. We commit to pushing the boundaries of scientific exploration, continuously seeking new solutions, and driving progress in medicine and genetics. Our mission is to make humanity better through cutting-edge research and development.

2. Ethical Excellence:
We uphold the highest ethical standards in all our endeavors. The well-being and dignity of individuals are at the heart of everything we do. We pledge to adhere to the strictest ethical guidelines, ensuring the responsible and safe use of our innovations.

3. Collaboration for a Shared Vision:
We recognize that our greatest accomplishments are achieved in partnership with like-minded organizations, institutions, and individuals. Collaboration and shared knowledge are central to our pursuit of progress.

4. Unwavering Commitment to Humanity:
We are steadfast in our mission to improve the lives of ordinary citizens. Our dedication extends beyond profits and market expansion; it reaches the communities we serve. Our work is guided by a genuine commitment to enhancing the human experience.

5. Adaptation to a Changing World:
We understand that the world is dynamic, and we embrace change. We actively seek to understand the evolving needs of humanity, adapting our focus and resources to address emerging challenges.

6. Transparency and Accountability:
We pledge transparency in all our actions and decisions. We hold ourselves accountable for the impact of our work, both positive and negative, and we welcome open dialogue with all stakeholders.

7. Sustained Learning and Growth:
Our commitment to bettering humanity drives us to continually learn and grow. We invest in the development of our team, fostering an environment of continuous improvement.

8. Responsiveness to Global Issues:
We recognize our responsibility to address pressing global issues. As global citizens, we actively engage in initiatives to mitigate environmental impact and contribute to a more sustainable future.

9. Inclusive Progress:
We strive for progress that benefits all, without discrimination or bias. We champion diversity, inclusion, and equal access to the benefits of our innovations.

10. Empowering Future Generations:
We work not only for the present but also for the future. We invest in the education and empowerment of future generations, so they may continue our mission to make humanity better.

This manifesto serves as our guiding light, illuminating our path as we embark on the journey of innovation, dedication, and the constant pursuit of a better world for all. We welcome all who share our vision to join us in this noble endeavor. Together, we make humanity better, one innovation at a time.

Charter

Centurion Bioengineering Charter

Preamble:

We, the members of Centurion Bioengineering, in order to advance the betterment of humanity, establish this charter as a guiding document for our organization. It reflects our commitment to ethical principles, innovation, and our unwavering dedication to enhancing the well-being of individuals and communities around the world.

Article I: Name and Purpose

Section 1.1 – Name:
The organization shall be known as “Centurion Bioengineering.”

Section 1.2 – Purpose:
The primary purpose of Centurion Bioengineering is to advance the well-being of humanity through the pursuit of innovative pharmaceutical and genetic research, while upholding the highest ethical standards.

*Article II: Values and Principles

Section 2.1 – Innovation:*
Centurion Bioengineering shall be guided by a commitment to innovation as a means to drive progress, improve the quality of life, and find new solutions to global challenges.

Section 2.2 – Ethics:
Centurion Bioengineering shall adhere to the strictest ethical standards in all research, development, and business activities. The organization shall prioritize the well-being and dignity of individuals, ensuring the responsible and safe use of its innovations.

Section 2.3 – Collaboration:
Centurion Bioengineering shall actively seek collaboration with like-minded organizations, institutions, and individuals, fostering an environment of shared knowledge and partnership to achieve shared goals.

Section 2.4 – Commitment to Humanity:
The organization’s actions and decisions shall reflect an unwavering commitment to improving the lives of ordinary citizens and the broader human community, transcending profit motives.

*Article III: Governance

Section 3.1 – Leadership:*
Centurion Bioengineering shall be led by a Board of Directors, comprising individuals who embody the organization’s values and principles. The Board shall provide strategic direction and oversee the organization’s activities.

Section 3.2 – Accountability:
The organization shall maintain transparency in all actions and decisions, holding itself accountable for its impact on society. Centurion Bioengineering welcomes open dialogue with all stakeholders.

*Article IV: Adaptation and Responsiveness

Section 4.1 – Adaptation:*
Centurion Bioengineering acknowledges the dynamic nature of the world and commits to adapting its focus and resources to address emerging challenges and opportunities.

Section 4.2 – Global Issues:
The organization shall actively engage in initiatives to mitigate its environmental impact and contribute to a more sustainable future. It recognizes its responsibility to address pressing global issues.

*Article V: Inclusivity and Equality

Section 5.1 – Inclusivity:*
Centurion Bioengineering shall champion diversity and inclusion, ensuring equal access to the benefits of its innovations. The organization shall not discriminate or show bias.

*Article VI: Empowerment of Future Generations

Section 6.1 – Education:*
Centurion Bioengineering shall invest in the education and empowerment of future generations, fostering an environment that encourages the pursuit of knowledge and progress for the betterment of humanity.

Article VII: Amendment of the Charter

This charter may be amended by a two-thirds majority vote of the Board of Directors, provided that any proposed amendment adheres to the organization’s values and principles.

Article VIII: Adoption

This charter shall come into effect upon its adoption by the Board of Directors of Centurion Bioengineering and shall remain in effect henceforth.